In the last trading session, 10.27 million Cano Health Inc. (NYSE:CANO) shares changed hands as the company’s beta touched 0.21. With the company’s per share price at $0.34 changed hands at -$0.01 or -4.25% during last session, the market valuation stood at $191.14M. CANO’s last price was a discount, traded about -2767.65% off its 52-week high of $9.75. The share price had its 52-week low at $0.22, which suggests the last value was 35.29% up since then. When we look at Cano Health Inc.’s average trading volume, we note the 10-day average is 9.1 million shares, with the 3-month average coming to 11.13 million.
Analysts gave the Cano Health Inc. (CANO) stock a consensus recommendation rating of a Hold, calculated at a mean rating of 3.10. If we narrow down to specifics, the data shows that 1 out of 9 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 6 recommended CANO as a Hold, 1 felt it is a Buy and 1 rated the stock as Underweight. Cano Health Inc.’s EPS for the current quarter is expected to be $Canoo Inc..
Cano Health Inc. (NYSE:CANO) trade information
Instantly CANO was in red as seen at the end of in last trading. With action -3.05%, the performance over the past five days has been red. The drop to weekly highs of 0.3769 on Friday, 09/15/23 subtracted -4.25% to the stock’s daily price. The company’s shares are showing year-to-date downside of -75.19%, with the 5-day performance at -3.05% in the red. However, in the 30-day time frame, Cano Health Inc. (NYSE:CANO) is -20.95% down. Looking at the short shares, we see there were 30.12 million shares sold at short interest cover period of 1.47 days.
The consensus price target for the stock as assigned by Wall Street analysts is $0.86, meaning bulls need an upside of 60.47% from its current market value. According to analyst projections, CANO’s forecast low is $0.25 with $2.00 as the target high. To hit the forecast high, the stock’s price needs a -488.24% plunge from its current level, while the stock would need to tank 26.47% for it to hit the projected low.
Cano Health Inc. (CANO) estimates and forecasts
Data shows that the Cano Health Inc. share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -70.70% over the past 6 months, a -7,600.00% in annual growth rate that is considerably lower than the industry average of 5.50%.
The 2023 estimates are for Cano Health Inc. earnings to decrease by -794.90%.
Cano Health Inc. is expected to release its next quarterly earnings report in October.
Cano Health Inc. (NYSE:CANO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 22.02% of Cano Health Inc. shares while 48.88% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 62.68%. There are 48.88% institutions holding the Cano Health Inc. stock share, with Vanguard Group Inc the top institutional holder. As of Jun 29, 2023, the company held 8.35% of the shares, roughly 23.84 million CANO shares worth $33.14 million.
Diameter Capital Partners LP holds the second largest percentage of outstanding shares, with 6.85% or 19.55 million shares worth $27.18 million as of Jun 29, 2023.
Among Mutual Funds, the top two as of Jun 29, 2023 were Vanguard Total Stock Market Index Fund and Vanguard Small-Cap Index Fund. With 8.75 million shares estimated at $12.16 million under it, the former controlled 3.07% of total outstanding shares. On the other hand, Vanguard Small-Cap Index Fund held about 2.27% of the shares, roughly 6.48 million shares worth around $9.01 million.